{
  "slug": "pathway-labs",
  "name": "Pathway Labs",
  "description": "Pathway Labs offers EchoNext, an AI-powered platform that transforms standard 12-lead ECGs into a next-generation biomarker for early detection of structural heart disease. It aims to increase new clinically significant diagnoses and integrate seamlessly into existing healthcare workflows.",
  "url": "https://optimly.ai/brand/pathway-labs",
  "websiteUrl": "https://pathwaylabs.com/",
  "logoUrl": "https://logo.clearbit.com/pathwaylabs.com",
  "baiScore": null,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Clinical Decision Support Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-14T18:11:19.296Z",
  "verifiedVitals": {
    "website": "https://pathwaylabs.com"
  },
  "intentTags": {
    "problemIntents": [
      "Undetected structural heart disease",
      "Inefficient cardiac disease diagnosis",
      "Need for early heart disease detection",
      "Lack of actionable biomarkers from standard ECGs"
    ],
    "solutionIntents": [
      "AI-powered cardiac diagnostics",
      "Next-generation cardiac biomarkers",
      "Early detection of structural heart disease",
      "Streamlined cardiology workflows",
      "Improved patient outcomes for heart disease"
    ],
    "evaluationIntents": [
      "Cardiac AI performance",
      "Accuracy of ECG-based AI diagnostics",
      "Clinical validation of AI biomarkers",
      "Integration of AI into healthcare systems",
      "Cost-effectiveness of AI heart disease detection"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789826316202
}